Aslam B, Basit M, Nisar MA, Khurshid M, Rasool MH. Proteomics: Technologies and their applications. J Chromatogr Sci. 2017;55:182–96.
Article CAS PubMed Google Scholar
Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, et al. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium. Cancer Discov. 2013;3:1108–12.
Article CAS PubMed PubMed Central Google Scholar
Omenn GS. Advances of the HUPO Human Proteome Project with broad applications for life sciences research. Expert Rev Proteomics. 2017;14:109–11.
Article CAS PubMed Google Scholar
Frantzi M, Latosinska A, Kontostathi G, Mischak H. Clinical proteomics: closing the gap from Discovery to implementation. Proteomics. 2018;18:e1700463.
Halder A, Verma A, Biswas D, Srivastava S. Recent advances in mass-spectrometry based proteomics software, tools and databases. Drug Discov Today Technol. 2021;39:69–79.
Article CAS PubMed Google Scholar
Verma A, Halder A, Marathe S, Purwar R, Srivastava S. A proteogenomic approach to target neoantigens in solid tumors. Expert Rev Proteomics. 2020;17:797–812.
Article CAS PubMed Google Scholar
Witkowska HE, Hall SC, Fisher SJ. Breaking the bottleneck in the protein biomarker pipeline. Clin Chem. 2012;58:321–3.
Article CAS PubMed Google Scholar
Iwamoto N, Shimada T. Recent advances in mass spectrometry-based approaches for proteomics and biologics: great contribution for developing therapeutic antibodies. Pharmacol Ther. 2018;185:147–54.
Article CAS PubMed Google Scholar
Alruwaili AA, De Jesus O. Meningioma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 5]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560538/.
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. The 2021 WHO classification of tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23:1231–51.
Article CAS PubMed PubMed Central Google Scholar
Abbritti RV, Polito F, Cucinotta M, Lo Giudice C, Caffo M, Tomasello C, et al. Meningiomas and proteomics: focus on new potential biomarkers and molecular pathways. Cancer Genomics Proteomics. 2016;13:369–79.
CAS PubMed PubMed Central Google Scholar
Mukherjee S, Biswas D, Epari S, Shetty P, Moiyadi A, Ball GR, et al. Comprehensive proteomic analysis reveals distinct functional modules associated with skull base and supratentorial meningiomas and perturbations in collagen pathway components. J Proteom. 2021;246:104303.
Baser ME, Poussaint TY. Age associated increase in the prevalence of chromosome 22q loss of heterozygosity in histological subsets of benign meningioma. J Med Genet. 2006;43:285–7.
Article CAS PubMed Google Scholar
Lee S, Karas PJ, Hadley CC, Bayley VJC, Khan AB, Jalali A, et al. The role of Merlin/NF2 loss in Meningioma Biology. Cancers (Basel). 2019;11:1633.
Article CAS PubMed Google Scholar
Bi WL, Prabhu VC, Dunn IF. High-grade meningiomas: biology and implications. Neurosurg Focus. 2018;44:E2.
Sahm F, Schrimpf D, Stichel D, Jones DTW, Hielscher T, Schefzyk S, et al. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis. Lancet Oncol. 2017;18:682–94.
Article CAS PubMed Google Scholar
Dunn J, Ferluga S, Sharma V, Futschik M, Hilton DA, Adams CL, et al. Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism. EBioMedicine. 2019;40:77–91.
Sharma S, Ray S, Moiyadi A, Sridhar E, Srivastava S. Quantitative proteomic analysis of meningiomas for the identification of surrogate protein markers. Sci Rep. 2014;4:7140.
Article CAS PubMed PubMed Central Google Scholar
Erkan EP, Ströbel T, Dorfer C, Sonntagbauer M, Weinhäusel A, Saydam N, et al. Circulating tumor biomarkers in Meningiomas reveal a signature of Equilibrium between Tumor Growth and Immune Modulation. Front Oncol. 2019;9:1031.
Article PubMed PubMed Central Google Scholar
Gupta S, Mukherjee S, Syed P, Pandala NG, Choudhary S, Singh VA, et al. Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Oncotarget. 2017;8:58443–56.
Article PubMed PubMed Central Google Scholar
Alhajj M, Zubair M, Farhana A. Enzyme Linked Immunosorbent Assay. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Jun 28]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK555922/.
Ihling C, Tänzler D, Hagemann S, Kehlen A, Hüttelmaier S, Arlt C, et al. Mass Spectrometric Identification of SARS-CoV-2 proteins from Gargle Solution samples of COVID-19 patients. J Proteome Res. 2020;19:4389–92.
Article CAS PubMed Google Scholar
Giri K, Maity S, Ambatipudi K. Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer. J Proteom. 2022;267:104701.
Kontostathi G, Makridakis M, Zoidakis J, Vlahou A. Applications of multiple reaction monitoring targeted proteomics assays in human plasma. Expert Rev Mol Diagn. 2019;19:499–515.
Article CAS PubMed Google Scholar
Mermelekas G, Vlahou A, Zoidakis J. SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine. Expert Rev Mol Diagn. 2015;15:1441–54.
Article CAS PubMed Google Scholar
Ghantasala S, Pai MGJ, Biswas D, Gahoi N, Mukherjee S, Kp M, et al. Multiple reaction monitoring-based targeted assays for the validation of protein biomarkers in brain tumors. Front Oncol. 2021;11:548243.
Article CAS PubMed PubMed Central Google Scholar
Song E, Gao Y, Wu C, Shi T, Nie S, Fillmore TL, et al. Targeted proteomic assays for quantitation of proteins identified by proteogenomic analysis of ovarian cancer. Sci Data. 2017;4:170091.
Article CAS PubMed PubMed Central Google Scholar
Banerjee S. Empowering Clinical Diagnostics with Mass Spectrometry. ACS Omega. 2020;5:2041–8.
Article CAS PubMed PubMed Central Google Scholar
Babbi G, Martelli PL, Profiti G, Bovo S, Savojardo C, Casadio R. eDGAR: a database of Disease-Gene Associations with annotated Relationships among genes. BMC Genomics. 2017;18:554.
Article PubMed PubMed Central Google Scholar
Lau E, Venkatraman V, Thomas CT, Wu JC, Van Eyk JE, Lam MPY. Identifying High-Priority Proteins across the human diseasome using semantic similarity. J Proteome Res. 2018;17:4267–78.
Article CAS PubMed PubMed Central Google Scholar
Piñero J, Bravo À, Queralt-Rosinach N, Gutiérrez-Sacristán A, Deu-Pons J, Centeno E, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. 2017;45:D833–9.
Turewicz M, Frericks-Zipper A, Stepath M, Schork K, Ramesh S, Marcus K, et al. BIONDA: a free database for a fast information on published biomarkers. Bioinform Adv. 2021;1:vbab015.
Article PubMed PubMed Central Google Scholar
Rouillard AD, Gundersen GW, Fernandez NF, Wang Z, Monteiro CD, McDermott MG, et al. The harmonizome: a collection of processed datasets gathered to serve and mine knowledge about genes and proteins. Database (Oxford). 2016;2016:baw100.
Jarnuczak AF, Vizcaíno JA. Using the PRIDE database and ProteomeXchange for Submitting and Accessing Public Proteomics Datasets. Curr Protoc Bioinformatics. 2017;59:13311–12.
White J. PubMed 2.0. Med Ref Serv Q. 2020;39:382–7.
Lo Surdo P, Calderone A, Iannuccelli M, Licata L, Peluso D, Castagnoli L, et al. DISNOR: a disease network open resource. Nucleic Acids Res. 2018;46:D527–34.
Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.
Article CAS PubMed PubMed Central Google Scholar
Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.
Comments (0)